Skip to content

Vitamin C for Prevention of Urinary Tract Infections in the Spinal Cord Injured

Vitamin C for Prevention of Urinary Tract Infections in the Spinal Cord Injured

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00869427
Enrollment
40
Registered
2009-03-26
Start date
2009-03-31
Completion date
2011-06-30
Last updated
2010-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury, Urinary Tract Infection

Keywords

UVI, Spinal cord injury, Prevention, Vitamin C

Brief summary

After spinal cord injury, patients have frequent urinary tract infections (UVI). Vitamin C is usually prescribed to prevent such infection, but the efficacy of the treatment is poorly documented. In the study, patients will be randomised either to receive vitamin C daily, or not, for one year, and clinical episodes of UVI will be registered. The null hypothesis is that vitamin C will not reduce the number of UVI episodes by 30%.

Detailed description

The study is an investigator-blind randomised parallel study on the efficacy of vitamin C to prevent urinary tract infections in stable, ambulatory spinal cord-injured patients. To be included, patients should have had at least 3 previous UVI episodes over the last two years. 40 patients are included. Patients are randomised to receive either 1 g vitamin C b.i.d. over 1 year, or no vitamin C. The main outcome is the number of clinical UVIs that have been treated with antibiotics.

Interventions

DRUGvitamin C

vitamin C 1g bid for 1 year

Sponsors

Dentsply Sirona Implants and Consumables
CollaboratorINDUSTRY
Sunnaas Rehabilitation Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* spinal cord injury * 3 or more episodes of UVI over previous 2 years

Exclusion criteria

* pregnancy * age \<18 * continuous use of antibiotics, hippuric acid or crane berry juice

Design outcomes

Primary

MeasureTime frame
Clinical episodes of UVI treated by antibioticsone year

Secondary

MeasureTime frame
Silent bacteriuriaone year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026